| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 152,476 | 108,541 | 67,202 | | Cost of Revenue | 48,582 | 33,766 | 22,993 | | | Gross Profit | 103,894 | 74,775 | 44,209 | | | Operating Expenses | | Research Development | 21,516 | 23,703 | 20,690 | | Selling General and Administrative | 100,747 | 74,652 | 58,511 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (18,369) | (23,580) | (34,992) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,939 | 648 | 330 | | Earnings Before Interest And Taxes | (15,430) | (22,932) | (34,662) | | Interest Expense | 474 | 854 | 657 | | Income Before Tax | (15,904) | (23,786) | (35,319) | | Income Tax Expense | 1,056 | 734 | 643 | | Minority Interest | 1,096 | 614 | 240 | | | | Net Income From Continuing Ops | (15,864) | (23,906) | (35,722) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,864) | (23,906) | (35,722) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,864) | ($23,906) | ($35,722) |
|
0.91% Nasdaq 
Income Statement
